Edwards Lifesciences Corporation logo
Edwards Lifesciences Corporation EW
$ 105.14 -0.18%
report update icon

Quarterly report 2026-Q3
added 11-04-2026

Edwards Lifesciences Corporation Revenue | EW

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Edwards Lifesciences Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
6.07 B 5.44 B 5.01 B 4.46 B 5.23 B 4.39 B 4.35 B 3.72 B 3.44 B 2.96 B 2.49 B 2.32 B 2.05 B 1.9 B 1.68 B - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.07 B 1.68 B 3.7 B

Quarterly Revenue Edwards Lifesciences Corporation

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2
1.72 B 1.74 B 1.65 B 1.57 B 1.55 B 1.53 B 1.41 B 1.39 B 1.35 B 1.37 B 1.33 B 1.27 B 1.24 B 1.28 B 1.22 B 430 M 1.32 B 1.37 B 1.34 B 1.33 B 1.31 B 1.38 B 1.22 B 1.19 B 1.14 B 925 M 1.13 B 1.17 B 1.09 B 1.09 B 993 M 978 M 907 M 944 M 895 M 888 M 822 M 842 M 884 M 768 M 739 M 759 M 697 M 671 M 616 M 617 M 590 M 618 M 607 M 575 M 522 M 536 M 496 M 517 M 497 M 510 M 448 M 482 M 459 M 430 M 413 M 431 M 404 M - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.74 B 404 M 962 M

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical devices industry

Issuer Revenue Price % 24h Market Cap Country
Nemaura Medical Nemaura Medical
NMRD
77 K - -17.8 % $ 2.74 M britainBritain
Butterfly Network Butterfly Network
BFLY
97.6 M $ 6.11 6.0 % $ 1.51 B usaUSA
Invacare Corporation Invacare Corporation
IVC
181 M - - $ 24.7 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
8.23 B $ 103.42 1.3 % $ 20.5 B usaUSA
Abbott Laboratories Abbott Laboratories
ABT
44.3 B $ 104.47 -0.23 % $ 182 B usaUSA
Align Technology Align Technology
ALGN
4.03 B $ 163.89 0.26 % $ 11.9 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
764 M $ 7.08 1.95 % $ 1.06 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
20.1 B $ 43.66 1.45 % $ 64.6 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
400 M $ 7.93 1.34 % $ 578 M israelIsrael
Aethlon Medical Aethlon Medical
AEMD
574 K $ 5.05 -0.59 % $ 3.4 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
2.58 B $ 369.72 3.22 % $ 10.1 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
52.8 M $ 2.44 -4.5 % $ 100 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
172 M - - $ 1.77 B usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
1.59 M - -5.86 % $ 30.6 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
1.37 B $ 48.11 -0.59 % $ 1.49 B usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
211 M $ 70.8 1.86 % $ 2.1 B costa-ricaCosta-rica
Medtronic PLC Medtronic PLC
MDT
36.4 B $ 100.7 -1.58 % $ 129 B usaUSA
Myomo Myomo
MYO
40.9 M $ 0.88 -3.85 % $ 36.8 M usaUSA
MiMedx Group MiMedx Group
MDXG
419 M $ 3.2 0.63 % $ 473 M usaUSA
Delcath Systems Delcath Systems
DCTH
85.2 M $ 19.7 1.7 % $ 706 M usaUSA
Electromed Electromed
ELMD
73.8 M $ 23.59 1.99 % $ 195 M usaUSA
Inogen Inogen
INGN
349 M $ 5.58 -1.85 % $ 148 M usaUSA
Globus Medical Globus Medical
GMED
2.94 B $ 70.5 0.73 % $ 9.53 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
139 M $ 2.07 -27.62 % $ 88.3 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
83.8 M $ 82.34 -1.33 % $ 1.05 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
13 M $ 0.26 -8.45 % $ 16.8 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
37 M $ 7.77 -1.21 % $ 220 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
402 M $ 2.49 2.05 % $ 305 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.25 K - -1.98 % $ 98.3 M usaUSA
AxoGen AxoGen
AXGN
225 M $ 56.98 2.9 % $ 2.62 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
52.7 M $ 0.5 -28.53 % $ 8.47 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
37.1 M $ 5.1 12.83 % $ 317 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
27.5 M $ 2.3 1.55 % $ 37.6 M usaUSA
Stryker Corporation Stryker Corporation
SYK
7.17 B $ 318.0 0.14 % $ 122 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
1.64 B $ 13.87 2.32 % $ 1.06 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
330 M $ 26.45 1.54 % $ 605 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
3.44 B $ 63.28 3.13 % $ 9.61 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
1.39 B $ 94.44 2.74 % $ 5.15 B britainBritain
Tandem Diabetes Care Tandem Diabetes Care
TNDM
290 M $ 16.97 -0.53 % $ 1.15 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
16.1 M $ 6.87 -2.97 % $ 208 M canadaCanada
LENSAR LENSAR
LNSR
58.4 M $ 4.91 -0.07 % $ 58.7 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
822 M $ 6.59 -1.27 % $ 261 M curacaoCuracao
Pulmonx Corporation Pulmonx Corporation
LUNG
90.5 M $ 2.69 -1.83 % $ 109 M usaUSA
InspireMD InspireMD
NSPR
8.98 M $ 0.68 4.58 % $ 43.7 M israelIsrael
InMode Ltd. InMode Ltd.
INMD
370 M $ 12.87 -0.43 % $ 832 M israelIsrael
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
236 M $ 31.67 0.81 % $ 743 M usaUSA
Outset Medical Outset Medical
OM
119 M $ 3.04 -3.8 % $ 46.2 M usaUSA
PAVmed PAVmed
PAVM
71 K $ 1.3 -13.91 % $ 872 K usaUSA
AVITA Medical AVITA Medical
RCEL
71.6 M $ 16.71 5.96 % $ 466 M australiaAustralia